A new vaccine strategy could help protect people from pandemic influenza before a strain-matched vaccine is ready, potentially reducing early infections and easing pressure on healthcare systems.
Researchers are proposing a new approach to influenza vaccination that could strengthen protection against future pandemics. The strategy, known as “Before Day One,” aims to use routine seasonal flu vaccination to provide some protection against new pandemic influenza viruses before a specific vaccine can be developed.
The proposal addresses a major weakness in current pandemic preparedness. When a new influenza virus emerges, scientists typically need to identify the strain, develop a matched vaccine, manufacture it and distribute it. This process can take valuable time, leaving populations vulnerable during the early stages of an outbreak.
The proposed approach would focus on developing broadly protective influenza vaccines that generate immune responses against parts of the virus that change less frequently. Researchers are considering targets such as hemagglutinin, neuraminidase and internal viral proteins that can stimulate T-cell responses.
According to modeling cited by the researchers, timing could be as important as vaccine effectiveness. A moderately effective vaccine given early in a pandemic could potentially prevent more infections than a highly effective vaccine introduced later.
Even a 10% reduction in infections during the first pandemic wave could help slow transmission and protect healthcare capacity. It could also give scientists more time to develop, manufacture and distribute a strain-matched pandemic vaccine.
The proposal does not suggest replacing seasonal flu vaccines. Instead, researchers envision vaccines that continue to protect against ordinary seasonal influenza while also offering baseline protection against emerging pandemic strains.
However, developing and testing such vaccines presents challenges. Scientists cannot conduct clinical trials against an unknown future pandemic strain. They would therefore need to rely on immune markers, animal studies and other evidence to estimate how well the vaccines might work.
If successful, the strategy could make annual influenza vaccination part of a broader pandemic preparedness system. Researchers believe this could provide a practical first line of defense against future influenza pandemics while also offering benefits during normal flu seasons.
For more health-related news
